MGMT and glioblastoma: Recently, Wu et al. have shown that the inhibition of PARylation by talazoparib (a PARP inhibitor) reduces MGMT functioning and therefore increases the sensitivity to TMZ of GBM cells with unmethylated MGMT promoter.